Lebenthal Global Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.39M Buy
5,979
+236
+4% +$54.6K 0.19% 89
2026
Q2
$1.22M Buy
5,743
+217
+4% +$42.6K 0.16% 92
2026
Q1
$1.08M Buy
5,526
+329
+6% +$63.9K 0.16% 103
2025
Q4
$902K Buy
5,197
+163
+3% +$29.7K 0.14% 105
2025
Q3
$959K Buy
5,034
+2,720
+118% +$483K 0.17% 91
2025
Q2
$416K Buy
2,314
+87
+4% +$15.1K 0.08% 146
2025
Q1
$377K Buy
+2,227
New +$366K 0.07% 154

Other funds holding DGX

Lebenthal Global Advisors's DGX Position: Q3 2026 in Review

Lebenthal Global Advisors increased its Quest Diagnostics (DGX) stake by 4.1% in Q3 2026, buying an estimated $54.6K and bringing the position to 5,979 shares worth $1.39M. The position accounts for 0.19% of the portfolio, ranked #89.

Lebenthal Global Advisors first reported a position in DGX in Q1 2025 and has held it in 7 quarters since. 1,137 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Lebenthal Global Advisors held 5,979 shares of Quest Diagnostics worth $1.39M as of Q3 2026.
  • Lebenthal Global Advisors bought 236 Quest Diagnostics shares in Q3 2026, an estimated $54.6K.
  • Quest Diagnostics made up 0.19% of Lebenthal Global Advisors's portfolio in Q3 2026, its #89 holding.
  • Lebenthal Global Advisors first reported a position in Quest Diagnostics in Q1 2025 and has held it in 7 quarters since.
  • 1,137 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Lebenthal Global Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.